[1] [1] P. G. Calzavara-Pinton,M. Venturini,R. Sala. Photodynamic therapy:update 2006. part 1:Photochemistry and photobiology [J]. J. Eur. Acad. Dermatol. Venereol.,2007,21(3):293-302

[2] [2] A. Juarranz,P. Jaén,F. Sanz-Rodríguez et al.. Photodynamic therapy of cancer. Basic principles and applications [J]. Clin. Transl. Oncol.,2008,10(3):148-154

[3] [3] B. T. Petersen,R. Chuttani,J. Croffie et al.. Photodynamic therapy for gastrointestinal disease [J]. Gastrointest Endosc.,2006,63(7):927-932

[4] [4] A. Sieroń,A. Kociarz-Grzesiok,A. Kawczyk-Krupka et al.. Application of photodynamic therapy in the treatment of premalignant and malignant changes of head and neck[J]. Wiad Lek.,2008,61(10-12):283-287

[5] [5] P. Jichlinski. Photodynamic applications in superficial bladder cancer:facts and hopes [J]. J. Environ. Pathol. Toxicol. Oncol.,2006,25(1-2):441-451

[6] [6] C. M. Moore,D. Pendse,M. Emberton et al.. Photodynamic therapy for prostate cancer a review of current status and future promise[J]. Nat. Clin. Pract. Urol.,2009,6(1):18-30

[7] [7] Zhang Hongyu,Ma Wenjiang,Zou Zhaohui et al.. Generation of antitumor vaccines for H22 tumor on mouse using photodynamic therapy[J]. Chinese J. Lasers,2008,35(4):631-634

[8] [8] L. R. Braathen,R. M. Szeimies,N. Basset-Seguin et al.. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer:an international consensus. international society for photodynamic therapy in dermatology,2005[J]. J. Am. Acad. Dermatol.,2007,56(1):125-143

[9] [9] G. Buggiani,M. Troiano,R. Rossi et al.. Photodynamic therapy:off-label and alternative use in dermatological practice [J]. Photodiagn. Photodyn. Ther.,2008,5(2):134-138

[10] [10] J. N. Silva,P. Filipe,P. Morlière et al.. Photodynamic therapy:dermatology and ophthalmology as main fields of current applications in clinic [J]. Biomed. Mater. Eng.,2008,18(4-5):319-327

[11] [11] A. Derkacz. Laser therapy application in invasive cardiology. current state and future trends [J]. Przegl. Lek.,2004,61(1):35-38

[12] [12] M. Wainwright. Local treatment of viral disease using photodynamic therapy [J]. Int. J. Antimicrob. Agents.,2003,21(6):510-520

[13] [13] D. Kacerovska,K. Pizinger,M. Kumpova et al.. Genital warts treated by photodynamic therapy[J]. Skinmed.,2007,6(6):295-297

[14] [14] Bo Baoxue,Gao Xin,Qiao Zhongliang et al.. Characteristics of high power volume-Bragg-grating external cavity semiconductor lasers[J]. Chinese J. Lasers,2008,35(4):501-504

[15] [15] Shi Jiawei,Liang Qingcheng,Cao Junsheng et al.. Junction voltage saturation and quality of high power semiconductor lasers[J]. Chinese J. Lasers,2008,35(9):1346-1349

[16] [16] Xia Wei,Ma Deying,Wang Ling et al.. High power 650 nm red semiconductor laser with transparent window[J]. Chinese J. Lasers,2007,34(9):1182-1184

[17] [17] R. R. Wang,L. M. Yang,Y. H. Wang et al.. Sifuvirtide,a potent HIV fusion inhibitor peptide[J]. Biochem. Biophys. Res. Commun.,2009,382(3):540~544

[18] [18] R. R. Wang,Q. Gu,Y. H. Wang et al.. Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis[J]. J. Ethnopharmacol.,2008,117(2):249-256

[19] [19] M. Wainwright. Methylene blue derivatives suitable photoantimicrobials for blood product disinfection [J]. Int. J. Antimicrob. Agents.,2000,16(4):381-394

[20] [20] S. Kiertiburanakul,S. Sungkanuparph. Emerging of HIV drug resistance:epidemiology,diagnosis,treatment and prevention[J]. Curr. HIV Res.,2009,7(3):273-278

[21] [21] S. K. Chiao,D. L. Romero,D. E. Johnson. Current HIV therapeutics:mechanistic and chemical determinants of toxicity [J]. Curr. Opin. Drug. Discov. Devel.,2009,12(1):53-60

[22] [22] B. G. Solheim,J. Seghatchian. Update on pathogen reduction technology for therapeutic plasma:an overview [J]. Transfus. Apher. Sci.,2006,35(1):83-90

[23] [23] B. Horowits,S. Rywkin,H. Margolis-Nunno et al.. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates [J]. Blood Cells.,1992,18(1):141-149

[24] [24] D. S. Dimitrov,R. Blumenthal. Photoinactivation and kinetics of membrane fusion mediated by the human immunodeficiency virus type 1 envelope glycoprotein [J]. J. Virol.,1994,68(3):1956-1961

[25] [25] C. Vever-Bizet,A. S. Boutorine,O. Delgado et al.. Targeting of HIV gp120 by oligonucleotide-photosensitizer conjugates. light-induced damages [J]. FEBS Lett.,1999,462(3):467-471

[26] [26] Yu Li,Li Xiaoyuan. Advances in the second generation of photosensitizer hematoporphyrin monomenthyl ether and its clinical applications [J]. BME & Clin. Med.,2005,9(6):365-368

[27] [27] Huijuan Yin,Yingxin Li,Zhaohui Zou et al.. Inactivation of bovine immunodeficiency virus by photodynamic therapy with HMME[J]. Chin. Opt. Lett.,2008,6(12):944-946